250 related articles for article (PubMed ID: 33557355)
1. Sarcopenic Obesity in Non-Alcoholic Fatty Liver Disease-The Union of Two Culprits.
Emhmed Ali S; Nguyen MH
Life (Basel); 2021 Feb; 11(2):. PubMed ID: 33557355
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease in the over-60s: Impact of sarcopenia and obesity.
Wijarnpreecha K; Panjawatanan P; Aby E; Ahmed A; Kim D
Maturitas; 2019 Jun; 124():48-54. PubMed ID: 31097179
[TBL] [Abstract][Full Text] [Related]
3. Impact of Sarcopenia on the Severity of the Liver Damage in Patients With Non-alcoholic Fatty Liver Disease.
Zambon Azevedo V; Silaghi CA; Maurel T; Silaghi H; Ratziu V; Pais R
Front Nutr; 2021; 8():774030. PubMed ID: 35111794
[TBL] [Abstract][Full Text] [Related]
4. Sarcopenic obesity in fatty liver.
Merli M; Lattanzi B; Aprile F
Curr Opin Clin Nutr Metab Care; 2019 May; 22(3):185-190. PubMed ID: 30893090
[TBL] [Abstract][Full Text] [Related]
5. Impact of Sarcopenia on Non-Alcoholic Fatty Liver Disease.
Iwaki M; Kobayashi T; Nogami A; Saito S; Nakajima A; Yoneda M
Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839249
[TBL] [Abstract][Full Text] [Related]
6. Sarcopenia and fatty liver disease.
Kim JA; Choi KM
Hepatol Int; 2019 Nov; 13(6):674-687. PubMed ID: 31705444
[TBL] [Abstract][Full Text] [Related]
7. The Impact of Dysmetabolic Sarcopenia Among Insulin Sensitive Tissues: A Narrative Review.
Armandi A; Rosso C; Caviglia GP; Ribaldone DG; Bugianesi E
Front Endocrinol (Lausanne); 2021; 12():716533. PubMed ID: 34858322
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenic Obesity, Insulin Resistance, and Their Implications in Cardiovascular and Metabolic Consequences.
Hong SH; Choi KM
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31941015
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia and non-alcoholic fatty liver disease: Is there a relationship? A systematic review.
Tovo CV; Fernandes SA; Buss C; de Mattos AA
World J Hepatol; 2017 Feb; 9(6):326-332. PubMed ID: 28293382
[TBL] [Abstract][Full Text] [Related]
10. Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
Hong HC; Hwang SY; Choi HY; Yoo HJ; Seo JA; Kim SG; Kim NH; Baik SH; Choi DS; Choi KM
Hepatology; 2014 May; 59(5):1772-8. PubMed ID: 23996808
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia, sarcopenic obesity and nonalcoholic fatty liver disease.
Polyzos SA; Vachliotis ID; Mantzoros CS
Metabolism; 2023 Oct; 147():155676. PubMed ID: 37544590
[TBL] [Abstract][Full Text] [Related]
12. Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis.
Koo BK; Kim D; Joo SK; Kim JH; Chang MS; Kim BG; Lee KL; Kim W
J Hepatol; 2017 Jan; 66(1):123-131. PubMed ID: 27599824
[TBL] [Abstract][Full Text] [Related]
13. Sarcopenia in patients with non-alcoholic fatty liver disease: is it a clinically significant entity?
De Fré CH; De Fré MA; Kwanten WJ; Op de Beeck BJ; Van Gaal LF; Francque SM
Obes Rev; 2019 Feb; 20(2):353-363. PubMed ID: 30474288
[TBL] [Abstract][Full Text] [Related]
14. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
[TBL] [Abstract][Full Text] [Related]
15. Non-alcoholic fatty liver disease connections with fat-free tissues: A focus on bone and skeletal muscle.
Poggiogalle E; Donini LM; Lenzi A; Chiesa C; Pacifico L
World J Gastroenterol; 2017 Mar; 23(10):1747-1757. PubMed ID: 28348479
[TBL] [Abstract][Full Text] [Related]
16. Sarcopenic obesity.
Polyzos SA; Margioris AN
Hormones (Athens); 2018 Sep; 17(3):321-331. PubMed ID: 30014320
[TBL] [Abstract][Full Text] [Related]
17. Strong association between sarcopenic obesity and non-alcoholic fatty liver disease: Anobservational study with ISarcoPRMalgorithm.
Demirci S; Sezer S; Erdoğan K; Abdulsalam AJ; Kara Ö; Kara M
Clin Res Hepatol Gastroenterol; 2024 Jul; ():102412. PubMed ID: 38964606
[TBL] [Abstract][Full Text] [Related]
18. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
[TBL] [Abstract][Full Text] [Related]
19. Approaching the Sarcopenic Patient with Nonalcoholic Steatohepatitis-related Cirrhosis.
Gallo P; Flagiello V; Falcomatà A; Di Pasquale G; D'Avanzo G; Terracciani F; Picardi A; Vespasiani-Gentilucci U
J Clin Transl Hepatol; 2024 Mar; 12(3):278-286. PubMed ID: 38426198
[TBL] [Abstract][Full Text] [Related]
20. Gamma-glutamyl transferase is associated with sarcopenia and sarcopenic obesity in community-dwelling older adults: results from the Fifth Korea National Health and Nutrition Examination Survey, 2010-2011.
Hong N; Lee EY; Kim CO
Endocr J; 2015; 62(7):585-92. PubMed ID: 25913781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
